NO961460L - Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider - Google Patents

Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider

Info

Publication number
NO961460L
NO961460L NO961460A NO961460A NO961460L NO 961460 L NO961460 L NO 961460L NO 961460 A NO961460 A NO 961460A NO 961460 A NO961460 A NO 961460A NO 961460 L NO961460 L NO 961460L
Authority
NO
Norway
Prior art keywords
pct
date
pseudopeptides
sec
prevention
Prior art date
Application number
NO961460A
Other languages
English (en)
Norwegian (no)
Other versions
NO961460D0 (no
Inventor
Scott I Klein
Bruce F Molino
Original Assignee
Rhone Poulenc Rorer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Inc filed Critical Rhone Poulenc Rorer Inc
Publication of NO961460D0 publication Critical patent/NO961460D0/no
Publication of NO961460L publication Critical patent/NO961460L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • C07K5/06113Asp- or Asn-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961460A 1993-10-15 1996-04-12 Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider NO961460L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13882093A 1993-10-15 1993-10-15
PCT/US1994/012135 WO1995010295A1 (fr) 1993-10-15 1994-10-17 Peptides et pseudopeptides a groupe azacycloalkylalcanoyle ayant des proprietes antithrombotiques

Publications (2)

Publication Number Publication Date
NO961460D0 NO961460D0 (no) 1996-04-12
NO961460L true NO961460L (no) 1996-06-17

Family

ID=22483811

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961460A NO961460L (no) 1993-10-15 1996-04-12 Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider

Country Status (28)

Country Link
US (1) US5866685A (fr)
EP (1) EP0812205B1 (fr)
JP (1) JP3032297B2 (fr)
KR (1) KR100304332B1 (fr)
CN (1) CN1135717A (fr)
AT (1) ATE199727T1 (fr)
AU (1) AU703854B2 (fr)
BG (1) BG63166B1 (fr)
BR (1) BR9407839A (fr)
CA (1) CA2174097C (fr)
CZ (1) CZ291378B6 (fr)
DE (1) DE69426897T2 (fr)
DK (1) DK0812205T3 (fr)
ES (1) ES2155122T3 (fr)
FI (1) FI961634A (fr)
GR (1) GR3035581T3 (fr)
HK (1) HK1006225A1 (fr)
HU (1) HU222248B1 (fr)
NO (1) NO961460L (fr)
NZ (1) NZ275948A (fr)
PL (1) PL181749B1 (fr)
PT (1) PT812205E (fr)
RO (1) RO115520B1 (fr)
RU (1) RU2134695C1 (fr)
SG (1) SG64919A1 (fr)
SK (1) SK47796A3 (fr)
UA (1) UA44258C2 (fr)
WO (1) WO1995010295A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
US6274705B1 (en) 1996-05-02 2001-08-14 Aventis Pharmaceuticals Products Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
ATE199727T1 (de) * 1993-10-15 2001-03-15 Rhone Poulenc Rorer Pharma Antithrombotisch wirkende azacycloalkyl-alkanoyl- peptide und-pseudopeptide
AU733591B2 (en) * 1996-08-21 2001-05-17 Aventis Pharmaceuticals Inc. Stable non-hygroscopic crystalline form of N-(N-N-(4-(piperidin-4-yl)butanoyl)-N-ethylglycyl) compounds
IL129877A (en) * 1996-11-27 2004-08-31 Aventis Pharm Prod Inc A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent
WO1999019294A1 (fr) * 1997-05-14 1999-04-22 Aventis Pharmaceuticals Products Inc. Legal/Patents Preparation des pseudotetrapeptides azacycloalkylalcanoyles
ZA989241B (en) * 1997-10-10 1999-06-04 Rhone Poulenc Rorer Pharma Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
AU2844800A (en) * 1998-12-30 2000-07-24 Aventis Pharmaceuticals Products Inc. Process for preparing a stable non-hygroscopic crystalline n-(n-(n- piperdin- 4-yl)butanoyl)- n.ethylglycyl)- (l)-aspartyl) -ss-cyclohexylalanine amide
CN101735307B (zh) * 2008-11-18 2012-05-30 北京航空航天大学 一种血小板膜糖蛋白寡肽或其修饰物/衍生物以及它们的应用
EP3524235A1 (fr) * 2012-06-11 2019-08-14 The Cleveland Clinic Foundation Traitement et prévention des maladies cardiovasculaires et de la thrombose

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
FR2608160B1 (fr) * 1986-12-15 1989-03-31 Inst Nat Sante Rech Med Nouveaux derives peptidiques et leur application notamment en therapeutique
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US5037808A (en) * 1988-07-20 1991-08-06 Monsanto Co. Indolyl platelet-aggregation inhibitors
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US4992463A (en) * 1988-07-20 1991-02-12 Monsanto Company Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation
US5023233A (en) * 1989-07-28 1991-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
CA2066047A1 (fr) * 1989-09-29 1991-03-30 Scott I. Klein Peptides et pseudo-peptides antiplaquettaires
US5051405A (en) * 1989-10-10 1991-09-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptides and pseudopeptides
US5064814A (en) * 1990-04-05 1991-11-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptide and pseudopeptide derivatives
NZ239876A (en) * 1990-09-27 1993-12-23 Merck & Co Inc Glycyl-b-alanine derivatives and pharmaceutical compositions thereof.
IL99539A0 (en) * 1990-09-27 1992-08-18 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
AU661659B2 (en) * 1991-04-11 1995-08-03 Rhone-Poulenc Rorer International (Holdings) Inc. Anti-thrombotic peptide and pseudopeptide derivatives
ATE199727T1 (de) * 1993-10-15 2001-03-15 Rhone Poulenc Rorer Pharma Antithrombotisch wirkende azacycloalkyl-alkanoyl- peptide und-pseudopeptide

Also Published As

Publication number Publication date
DE69426897D1 (de) 2001-04-19
ATE199727T1 (de) 2001-03-15
HK1006225A1 (en) 1999-02-19
SK47796A3 (en) 1997-03-05
RU2134695C1 (ru) 1999-08-20
NO961460D0 (no) 1996-04-12
GR3035581T3 (en) 2001-06-29
UA44258C2 (uk) 2002-02-15
FI961634A0 (fi) 1996-04-12
DE69426897T2 (de) 2001-07-05
EP0812205A1 (fr) 1997-12-17
CA2174097C (fr) 2002-06-04
DK0812205T3 (da) 2001-04-17
SG64919A1 (en) 1999-05-25
CA2174097A1 (fr) 1995-04-20
AU703854B2 (en) 1999-04-01
JP3032297B2 (ja) 2000-04-10
WO1995010295A1 (fr) 1995-04-20
EP0812205B1 (fr) 2001-03-14
BG63166B1 (bg) 2001-05-31
EP0812205A4 (fr) 1999-03-31
RO115520B1 (ro) 2000-03-30
HUT73856A (en) 1996-09-30
BR9407839A (pt) 1997-05-13
AU8123794A (en) 1995-05-04
HU9600983D0 (en) 1996-06-28
PT812205E (pt) 2001-08-30
FI961634A (fi) 1996-05-23
NZ275948A (en) 1997-02-24
HU222248B1 (hu) 2003-05-28
US5866685A (en) 1999-02-02
ES2155122T3 (es) 2001-05-01
KR100304332B1 (ko) 2001-11-26
JPH09507213A (ja) 1997-07-22
CZ291378B6 (cs) 2003-02-12
PL313975A1 (en) 1996-08-05
CZ108496A3 (en) 1996-12-11
BG100544A (bg) 1996-11-29
PL181749B1 (pl) 2001-09-28
CN1135717A (zh) 1996-11-13

Similar Documents

Publication Publication Date Title
RU93054168A (ru) Димер молекулярного варианта аро-липопротеина, способ его получения, фармацевтическая композиция на его основе
WO2001078709A3 (fr) Traitement des maladies neurodegeneratives
YU46097A (sh) Nova klasa estara i njihove farmaceutske smeše
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
EA199900778A1 (ru) ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ И ИХ ИСПОЛЬЗОВАНИЕ ДЛЯ ИНГИБИРОВАНИЯ β-АМИЛОИДНОГО ПЕПТИДА
IL112111A (en) Peptides having growth hormone releasing properties and pharmaceutical compositions containing them
DK0812205T3 (da) Antithrombotiske azacycloalkylalkanoylpeptider og -pseudopeptider
UA26973A1 (uk) Засіб для профілактики судиhhих захворюваhь, які обумовлеhі дією глікопротеїhзв'язаhих пероксидів
FI952593A (fi) Hyytymistä estävä aine
BG103512A (en) Substituted pyramidine compounds and their application
MXPA03011502A (es) Aminoalcoholes sustituidos utiles en tratamiento de enfermedad de alzheimer.
CA2140010A1 (fr) Regulation de la coagulation du sang a l'aide d'un produit contenant du tcf-ii comme ingredient actif
FR2710844B1 (fr) Composition pour le traitement ou la prévention de l'herpès.
KR960000248A (ko) 골대사 질환 치료제
CA2065889A1 (fr) Augmentation du debit choroidien
NO961357L (no) Nye terapeutisk aktive peptidforbindelser i blodkoagulasjonskaskaden, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
MX9207343A (es) Derivados antitromboticos de acido diaminoalcanoico.
CA2060333A1 (fr) Utilisation de derives de la pyrimidobenzothiazine
RU95104302A (ru) Аппликационный материал лечебно-профилактического назначения
RU96113185A (ru) Раствор для лечения заболеваний и повреждений роговицы "кератан-с"
ES2080657A1 (es) Proteasas modificadas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application